Ongc Teri Biotech Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
- Paid Up Capital ₹ 25.00 Cr
- Company Age 17 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -26.10%
- Profit Growth -2.18%
- Ebitda -5.09%
- Net Worth 12.11%
- Total Assets 11.06%
About Ongc Teri Biotech
Ongc Teri Biotech Limited (OTBL) is a leading Public Limited Indian Non-Government Company incorporated in India on 26 March 2007 and has a history of 17 years and ten months. Its registered office is in Delhi, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 25.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Ongc Teri Biotech Limited India are Hem Chand as CFO and Prabhjyot Kaur as Company Secretary. Banwari Lal, Dipankar Saharia, Sudip Gupta, and One other member serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74120DL2007PLC161117
- Company No.
161117
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
26 Mar 2007
- Date of AGM
19 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Ongc Teri Biotech?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Banwari Lal  | Managing Director | 26-Mar-2007 | Current |
| Hem Chand | CFO | 04-May-2021 | Current |
| Prabhjyot Kaur | Company Secretary | 12-Apr-2024 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dipankar Saharia | Director | 23-Mar-2023 | Current |
| Sudip Gupta | Director | 21-Jun-2023 | Current |
| Sushma Rawat | Director | 10-Jan-2023 | Current |
Financial Performance of Ongc Teri Biotech.
Ongc Teri Biotech Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 26.1% decrease. The company also saw a slight decrease in profitability, with a 2.18% decrease in profit. The company's net worth Soared by an impressive increase of 12.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ongc Teri Biotech?
In 2021, Ongc Teri Biotech had a promoter holding of 99.20% and a public holding of 0.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Oil And Natural Gas Corporation LimitedSushma Rawat is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ongc Teri Biotech?
Ongc Teri Biotech has a workforce of 17 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ongc Teri Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ongc Teri Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
